Transitional cell carcinoma risk factors: Difference between revisions
No edit summary |
|||
Line 38: | Line 38: | ||
* [[Congenital]] bladder anomalies | * [[Congenital]] bladder anomalies | ||
:*[[Urachus]] | :*[[Urachus]] | ||
:*[[Bladder | :*[[Bladder exstrophy|Exstrophy]] | ||
* Aristolochic acids | * Aristolochic acids | ||
Revision as of 18:44, 23 February 2016
Transitional cell carcinoma Microchapters |
Differentiating Transitional cell carcinoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Transitional cell carcinoma risk factors On the Web |
American Roentgen Ray Society Images of Transitional cell carcinoma risk factors |
Directions to Hospitals Treating Transitional cell carcinoma |
Risk calculators and risk factors for Transitional cell carcinoma risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Common risk factors in the development of transitional cell carcinoma are smoking, occupational exposure to chemicals, chronic bladder irritation, chemotherapy, radiation therapy, arsenic, personal history of cancer in the urinary tract, congenital bladder anomalies, and aristolochic acids.
Risk Factors
Common risk factors in the development of transitional cell carcinoma are:[1][2]
- Smoking tobacco is the strongest risk factor for developing cancer of the renal pelvis or ureter.
- Risk increases with the length of time a person smokes and with the number of cigarettes smoked.
- Phenacetin
- Human papilloma virus
- Balkan nephropathy
- Occupational exposure to chemicals
- Textiles
- Rubber
- Paint
- Leather
- Dye
- Metal
- Machining
- Plastics
- Transportation
- Chronic bladder irritation
-
- Trauma
- Radiation therapy
- Arsenic
- Personal history of cancer in the urinary tract
- Congenital bladder anomalies
- Aristolochic acids
References
- ↑ Risk factors for bladder cancer. Canadian Cancer Society 2015. http://www.cancer.ca/en/cancer-information/cancer-type/renal-pelvis-and-ureter/risks/?region=ab Accessed on February 10, 2016
- ↑ Kirkali, Ziya; Tuzel, Emre (2003). "Transitional cell carcinoma of the ureter and renal pelvis". Critical Reviews in Oncology/Hematology. 47 (2): 155–169. doi:10.1016/S1040-8428(03)00079-9. ISSN 1040-8428.